High field MRI: clinical applications and safety - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

High field MRI: clinical applications and safety

Description:

Relaxation times, MT, diffusion, perfusion/ blood volume. Neuroapplications ... HASTE. FISP. Appropriate fitting. Capillary. Bed. What would we like to measure? ... – PowerPoint PPT presentation

Number of Views:77
Avg rating:3.0/5.0
Slides: 25
Provided by: mrcent
Category:

less

Transcript and Presenter's Notes

Title: High field MRI: clinical applications and safety


1
(No Transcript)
2
Quantitative methods and investigating BOLD
mechanisms
  • Penny Gowland

Susan Francis
3
Quantitative Imaging
  • Relaxation times, MT, diffusion, perfusion/ blood
    volume
  • Neuroapplications
  • BOLD mechanisms
  • Cortical layering
  • MS etc
  • Cancer

4
Quantitative imaging
  • Rapid imaging sequences
  • EPI
  • HASTEFISP
  • Appropriate fitting

5
What would we like to measure?
  • CBV changes- venous and arterial
  • CBF changes
  • Oxygenation changes

REST
Glucose and O2
Venule
Arteriole
Capillary Bed
Glucose and O2
6
What do we want to measure?
  • CBV changes- venous and arterial
  • CBF changes
  • Oxygenation changes

ACTIVE
Glucose and O2
Arteriole
Venule
Capillary Bed
Glucose and O2
7
What do we want to measure?
  • CBV changes- venous and arterial
  • CBF changes
  • Oxygenation changes
  • With a temporal resolution sufficient to test
    models of HDR

Stimulus
0
30
60
Time (s)
8 s
Time (s)
Post stimulus undershoot
Initial dip
8
Measuring total DCBV by T2 effect of contrast
agents
  • (and DY)

9
Typical R2 timecourse
30
29
28
27
-1
26
R2 / s
25
24
Infusion
23
22
-2
0
2
4
6
8
10
12
14
16
18
Time / min
10
Understanding the HDR
  • Now repeating the study at higher temporal
    resolution, and shorter paradigm

1st Block
1100
2nd Block
3rd Block
4th Block
600
5th Block
EPI Signal (a.u.)
-5
15
35
55
5
Time (s)
Stimulus
Button press
11
Measuring Venous Blood Volume using multiecho T2
  • And oxygen extraction

12
Blood oxygenation effect on T2
p
p
p
p
p
p/2
tcp
13
Measuring DCBV by T1 effect
14
Measuring DCBV by T1 effect
  • Assuming fast exchange, in the presence of CA,
    the T1 of a voxel is given by

Schwarzbauer et al., Magn. Res. Med., 1993
15
ME-LL-EPI sequence
TR
a0
ME-EPI
ME-EPI
ME-EPI
ME-EPI
TA
TI
TA
TA
Broadening Gradient
Rewind gradient
Signal
T2 decay
TE1
TE2
16
T1 during an infusion of CA
1.14
1.13
1.12
1.11
Tl (s)
1.1
1.09
Stimulus
1.08
1.07
1.06
0
120
240
360
480
600
720
840
960
time (s)
Washout
CA given
17
Results
  • DCBVtot 27
  • Rise times similar, DCBV falls slower than T2
  • Faster changes than observed by Mandeville in
    anaesthetized rats (T2 method)

50
10
CBV
40
8
T2
30
6
CBV change ()
T2 change ()
20
4
10
2
0
0
80
120
0
20
40
60
100
Time (s)
-10
-2
18
Combining CBV and CBF measurements
19
LLEPI-FAIR
  • LL-EPI with alternating selective and
    non-selective (S/NS) inversion pulses
  • Better sensitivity than FAIR
  • Previous models (ITS-FAIR, Turbo-TILT) can be
    improved
  • Did not take account of transit times
  • Starting magnetization different in NS and S
    cases
  • cannot model difference signal

a0
EPI
EPI
EPI
EPI
TI
TA
20
Results
  • CBF increases by 85 on activation

21
Measuring arterial CBVa
22
EPI star with diffusion weighting
With and without diffusion weighting which will
suppress signal from arteries
23
EPI star with diffusion weighting
With and without diffusion weighting which will
suppress signal from arteries
24
CBVa using EPIstar
0.9
0.8
0.7
0.6
Change
0.5
0.4
0.3
0.2
0.1
0
0
1000
2000
3000
4000
5000
1
0.8
0.6
Change
0.4
0.2
0
0
1000
2000
3000
4000
5000
Inversion Time (ms)
Write a Comment
User Comments (0)
About PowerShow.com